Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Upper gastrointestinal ulceration with alendronate.

Literature DB >> 10063916

Upper gastrointestinal ulceration with alendronate.

J L Wallace.

Abstract

Entities: Chemical Disease

Mesh：

Substances：

Year: 1999 PMID： 10063916 DOI： 10.1023/a:1026650316788

Source DB: PubMed Journal: Dig Dis Sci ISSN： 0163-2116 Impact factor: 3.199

× No keyword cloud information.

11 in total

1. "Pill esophagitis"--the case of alendronate.

Authors: D O Castell
Journal: N Engl J Med Date: 1996-10-03 Impact factor: 91.245

2. Comparative study of potential for bisphosphonates to damage gastric mucosa of rats.

Authors: C P Peter; M V Kindt; J A Majka
Journal: Dig Dis Sci Date: 1998-05 Impact factor: 3.199

3. Nonclinical model for assessing gastric effects of bisphosphonates.

Authors: M A Blank; B L Ems; G W Gibson; W R Myers; S K Berman; R J Phipps; P N Smith
Journal: Dig Dis Sci Date: 1997-02 Impact factor: 3.199

4. Alendronate induces gastric injury and delays ulcer healing in rodents.

Authors: S N Elliott; W McKnight; N M Davies; W K MacNaughton; J L Wallace
Journal: Life Sci Date: 1998 Impact factor: 5.037

5. Primary amino-bisphosphonates: a new class of gastrotoxic drugs--comparison of alendronate and aspirin.

Authors: D Y Graham; H M Malaty; R Goodgame
Journal: Am J Gastroenterol Date: 1997-08 Impact factor: 10.864

Review 6. Bisphosphonates: preclinical aspects and use in osteoporosis.

Authors: H A Fleisch
Journal: Ann Med Date: 1997-02 Impact factor: 4.709

7. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group.

Authors: D M Black; S R Cummings; D B Karpf; J A Cauley; D E Thompson; M C Nevitt; D C Bauer; H K Genant; W L Haskell; R Marcus; S M Ott; J C Torner; S A Quandt; T F Reiss; K E Ensrud
Journal: Lancet Date: 1996-12-07 Impact factor: 79.321

8. Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group.

Authors: U A Liberman; S R Weiss; J Bröll; H W Minne; H Quan; N H Bell; J Rodriguez-Portales; R W Downs; J Dequeker; M Favus
Journal: N Engl J Med Date: 1995-11-30 Impact factor: 91.245